Additionally, intrathecal PACAP38 administration may lead to heightened activity of PACAP receptors, which can induce a sustained increase in sympathetic tone, potentially exacerbating hypertension [110]. The gene discussed is ADCYAP1; the disease is hypertensive disorder.